Leviathan Gas Reservoir Hits Record $843 Million in Quarterly Revenue

Leviathan natural gas reservoir posted record revenues of $843 million in the third quarter, driven by high export demand and expanded pipeline capacity to Egypt and Jordan.

Leviathan Gas Reservoir Hits Record $843 Million in Quarterly Revenue
Photo-illustration WireIsrael: AI Generated

Leviathan natural gas reservoir generated record-breaking revenues of $843 million in the third quarter, driven by robust export pricing and a significant expansion in production capacity. According to financial statements released by NewMed Energy, which holds a 45.43% stake in the offshore field, quarterly revenues surged to $382.2 million, translating to the unprecedented aggregate figure for the entire reservoir.

The revenue milestone reflects strong export demand for natural gas supplied to Egypt and Jordan, priced through a confidential formula pegged to Brent crude oil benchmarks. Brent prices remained elevated over the previous two quarters due to regional disruptions, including the closure of the Strait of Hormuz amid conflict with Iran. Furthermore, expanded export infrastructure—specifically the Ashkelon-Ashdod pipeline operated by Natural Gas Lines (Natgas)—enabled Leviathan production to reach an all-time high of 3.6 billion cubic meters (BCM) during the quarter, compared to 2.7 BCM in the previous quarter and 3.1 BCM in the same period of 2025.

Profit Growth and Royalty Increases

Despite the record top-line performance, net profits grew at a more modest rate due to rising debt servicing costs and higher overriding royalties. NewMed fully recovered its initial investment within parent company Delek Group, which automatically triggered an increase in the overriding royalty paid to the parent company from 1.5% to 6% of wellhead revenues. Consequently, total royalties paid by NewMed climbed from $40 million in the third quarter of 2025 to $78 million in the current period.

Net profit rose by 26% year-over-year, reaching $162 million compared to $128.5 million in the corresponding quarter last year. At the same time, the state treasury is projected to collect approximately $200 million in total gas revenues for the quarter through direct royalties and corporate taxes from the reservoir partners, which include Chevron and Ratio Energies.

Market Analysis and Outlook

Investment advisor and analyst Lior Wider, head of the "Machpil Revach" information service, emphasized the strategic importance of the offshore asset:

"Third-quarter results illustrate the strength of the Leviathan reservoir as a premier strategic cash-generating asset. The completion of pipeline expansion projects translates directly into revenue and solidifies the company's position as a dominant regional energy exporter. However, the surge in overriding royalties represents a predictable yet substantial weight on profitability moving forward."

Wider added that the company's exploratory focus on opportunities in Venezuela signals a desire for geographic diversification, carrying notable upside potential alongside elevated geopolitical and operational risks. NewMed currently trades at a price-to-earnings multiple of approximately 9.5, offering a free cash flow yield of about 8% and a dividend yield close to 5%, demonstrating business model resilience amid complex macroeconomic conditions.

Related News